Codexis Inc (CDXS) - חוב להון עצמי

Codexis, Inc. (CDXS) dominates the development of custom proteins for medicine and nutrition, leveraging its AI system and extensive patent portfolio. This price trend chart shows that the total debt-to-equity ratio is 2.36. The business relies on CodeEvolver to help partners optimize costs. A network of global carriers ensures supply stability, eliminating disruptions in the delivery of critical biocomponents.

The total debt-to-equity ratio measures the proportion of borrowed funds in the financing structure relative to the company's own resources. Low values for this metric indicate high financial autonomy and resilience to market shocks. By analyzing the total debt/equity chart, an investor can see the current leverage level, which for Codexis, Inc. (CDXS) is 2.36. This ratio confirms the company's balanced debt load, ensuring full coverage of operating expenses and investment costs through stable cash flows.